These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16838382)

  • 21. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.
    Humbert M; Antoni S; Brill B; Landersz M; Rodes B; Soriano V; Wintergerst U; Knechten H; Staszewski S; von Laer D; Dittmar MT; Dietrich U
    Eur J Immunol; 2007 Feb; 37(2):501-15. PubMed ID: 17236253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of VIP/NTM-reactive natural antibodies in therapy of HIV disease.
    Veljkovic V; Metlas R
    Int Rev Immunol; 2004; 23(5-6):437-45. PubMed ID: 15370275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1.
    Babaahmady K; Bergmeier LA; Lehner T
    AIDS; 2008 Jul; 22(11):1267-76. PubMed ID: 18580605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV pseudovirion vaccine exposing Env "fusion intermediates"-response to immunisation in human CD4/CCR5-transgenic rats.
    Bosch V; Pfeiffer T; Devitt G; Allespach I; Ebensen T; Emerson V; Guzman CA; Keppler OT
    Vaccine; 2009 Apr; 27(16):2202-12. PubMed ID: 19428834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
    Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
    J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity.
    Nishiyama Y; Mitsuda Y; Taguchi H; Planque S; Hara M; Karle S; Hanson CV; Uda T; Paul S
    J Mol Recognit; 2005; 18(4):295-306. PubMed ID: 15706608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response to gp120 of HIV: antibody spectrotype and inhibitory activity on T cell functions.
    Aiuti F; Pontesilli O; Biselli R; Matricardi PM; Lovigu C; Carlesimo M; Nisini R; Mezzaroma I; Pinter E; Varani AR
    Pharmacol Res; 1992 Sep; 26 Suppl 2():64-5. PubMed ID: 1409329
    [No Abstract]   [Full Text] [Related]  

  • 30. Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs.
    Nishiyama Y; Taguchi H; Luo JQ; Zhou YX; Burr G; Karle S; Paul S
    Arch Biochem Biophys; 2002 Jun; 402(2):281-8. PubMed ID: 12051675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention. Antibody that neutralizes most HIV strains discovered.
    AIDS Policy Law; 2005 Mar; 20(6):5. PubMed ID: 15844220
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospects for immunotherapeutic proteolytic antibodies.
    Zhou YX; Karle S; Taguchi H; Planque S; Nishiyama Y; Paul S
    J Immunol Methods; 2002 Nov; 269(1-2):257-68. PubMed ID: 12379366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic antibodies and their applications.
    Hanson CV; Nishiyama Y; Paul S
    Curr Opin Biotechnol; 2005 Dec; 16(6):631-6. PubMed ID: 16243512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Chemical Society meeting. Arraymaker speeds analyses by months.
    Service RF
    Science; 2003 Oct; 302(5642):47. PubMed ID: 14526057
    [No Abstract]   [Full Text] [Related]  

  • 35. Broadly distributed chemical reactivity of natural antibodies expressed in coordination with specific antigen binding activity.
    Planque S; Taguchi H; Burr G; Bhatia G; Karle S; Zhou YX; Nishiyama Y; Paul S
    J Biol Chem; 2003 May; 278(22):20436-43. PubMed ID: 12668670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of proteases as cofactors for antibody-dependent enhancement of HIV.
    Zoellner B; Feucht HH; Laufs R
    AIDS; 1992 Aug; 6(8):887-8. PubMed ID: 1418792
    [No Abstract]   [Full Text] [Related]  

  • 37. Catalytic antibody (catabody) platform for age-associated amyloid disease: From Heisenberg's uncertainty principle to the verge of medical interventions.
    Planque SA; Massey RJ; Paul S
    Mech Ageing Dev; 2020 Jan; 185():111188. PubMed ID: 31783036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific amyloid β clearance by a catalytic antibody construct.
    Planque SA; Nishiyama Y; Sonoda S; Lin Y; Taguchi H; Hara M; Kolodziej S; Mitsuda Y; Gonzalez V; Sait HB; Fukuchi K; Massey RJ; Friedland RP; O'Nuallain B; Sigurdsson EM; Paul S
    J Biol Chem; 2015 Apr; 290(16):10229-41. PubMed ID: 25724648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.
    Planque SA; Mitsuda Y; Chitsazzadeh V; Gorantla S; Poluektova L; Nishiyama Y; Ochsenbauer C; Morris MK; Sapparapu G; Hanson CV; Massey RJ; Paul S
    AIDS; 2014 Sep; 28(15):2201-11. PubMed ID: 25022597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4 binding determinant mimicry for HIV vaccine design.
    Nishiyama Y; Planque S; Hanson CV; Massey RJ; Paul S
    Front Immunol; 2012; 3():383. PubMed ID: 23251137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.